Nostos Genomics is a company focused on advancing rare disease diagnostics with an AI-driven variant interpretation platform called AION. Their mission is to turn genomic data into actionable insights to help labs speed up genetic testing, providing clear and fast diagnoses for patients with genetic diseases.

Nostos Genomics aims to address the bottleneck in genomics, which is the interpretation of variants and identification of disease-causing mutations, not the sequencing itself. Their platform AION offers automated variant interpretation that is fast, reliable, and scalable, improving diagnostic yield by more than 50% over traditional rules-based classification methods.

They focus on enabling genetic testing labs to concentrate on their core activities while their AI platform handles the complex task of variant interpretation, generating comprehensive reports and exports automatically within minutes.